US 11060089
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
granted A61KA61K31/7105A61K9/0019
Quick answer
US patent 11060089 (Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene) held by Sarepta Therapeutics, Inc. expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/7105, A61K9/0019, A61K9/0053, A61P